TIETOJA TÄSTÄ JAKSOSTA

Englanti
Yhdysvallat

TRANSKRIPTIO 🔗

HAE EDELLISIÄ EPISODEJA

Hae kanavan Medical Industry Feature vanhoja jaksoja.

MUITA jaksoja TÄSSÄ PODCASTISSA

Guest: Howard Fine, M.D. Dr. Howard Fine, a neuro-oncologist at NewYork-Presbyterian and Weill Cornell Medicine, discusses how a new approach to glioblastoma research may expand treatment options and advance precision oncology. His preclinical model, GLICO, uses cerebral organoids, or mi…
What do large registry data reveal about outcomes after intraocular foreign body removal, and how should those findings shape surgical planning and patient counseling? In this episode of New Retina Radio Journal Club with VBS, Jordan Deaner, MD, moderates a discussion with Vaidehi Dedania, MD, and …
Host: Jennifer Caudle, DO, FACOFP Guest: Laura Sass, MD Pediatric influenza carries a significant clinical burden, with children under four experiencing one of the highest rates of influenza-related illness, healthcare visits, and hospitalization.1,2 Seasonal influenza vaccination re…
Host: Maria Berrocal How much money are retina surgeons losing on secondary IOL procedures? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Nimesh "Nemo" Patel, MD, whose research uncovered how many cases are unprofitable under current Medicare reimbursem…
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Erin D. Michos, MD, MHS Severe hypertriglyceridemia (sHTG) affects more than 3 million people, but it often flies under the clinical radar.1-3 When triglycerides are at or above a 500 mg/dL threshold, it’s no longer just an isolated lab…
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin ReachMD:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.